Skip to content Skip to navigation

Medication

Five facts about new versions of buprenorphine

January 13, 2017  |  Gary A. Enos, Editor
article
Injectable and implant versions of buprenorphine are seen as potentially significant breakthroughs in improving medication adherence and reducing diversion.

FDA will remove warning language on drugs for smoking cessation

December 19, 2016  |  Gary A. Enos, Editor
news
Results of a clinical trial have convinced the Food and Drug Administration (FDA) that the risk of neuropsychiatric adverse events from the brand-name drugs Chantix and Zyban is lower than originally believed.

Settlement over prescribing practices puts spotlight on buprenorphine clinics

December 2, 2016  |  Gary A. Enos, Editor
article
A well-regarded chain of buprenorphine treatment operations has agreed to pay a civil settlement in a case that in part speaks to concerns about the mix of services in medication-assisted treatment facilities.

App from SAMHSA guides medication treatment for opioid dependence

December 1, 2016  |  Gary A. Enos, Editor
news
The new MATx app is designed to share treatment strategies and other resources for the use of medications to treat opioid use disorders.

Transformed thinking gives rise to center of excellence in addiction medicine

November 23, 2016  |  Gary A. Enos, Editor
article
In establishing unified addiction services that earned a first-ever recognition this month, the Center for Addiction Science in Tennessee showed how patients can flourish when they receive care in a humane manner.

Midlevel practitioners will soon prescribe buprenorphine

November 22, 2016  |  Julie Miller, Editor in Chief
article
A new 2017 federal policy will allow physician assistants and nurse practitioners to prescribe buprenorphine. Previously, only physicians were authorized to prescribe the medication.

Surgeon General's report on drugs uses compassionate, consumer-friendly language

November 21, 2016  |  Alison Knopf, Contributing Writer
article
In taking a consumer-accessible approach in his groundbreaking report on alcohol and drugs, the U.S. Surgeon General has created a document that could become the go-to information guide for families seeking help.

Research summary cites shortcomings in treatment of co-occurring alcohol use, depression

November 16, 2016  |  Gary A. Enos, Editor
news
A report from the University at Buffalo's Research Institute on Addictions states that most addiction treatment programs remain unprepared to address common co-occurring depression.

Health home model allows OTPs to cast a wider net

November 15, 2016  |  Rachael Zimlich, RN, Contributing Writer
article
Not only does the promising new health-home model require extra work in care coordination, it also requires a change in the way clinicians are thinking about care delivery.

Opioid treatment program weaves in hepatitis C care, despite payment obstacles

November 7, 2016  |  Gary A. Enos, Editor
article
The potential of newer drugs to treat the hepatitis C virus has helped drive Rhode Island organization CODAC Inc.'s move to establish an on-site HCV clinic.

Fentanyl, carfentanil prompt higher naloxone dosage

October 24, 2016  |  Tom Valentino, Senior Editor
article
Two expert panels have voted to recommend that the FDA increase the minimum dosage of naloxone in the wake of climbing overdose rates involving fentanyl and carfentanil.

Methadone remains vital in buprenorphine era

October 20, 2016  |  Alison Knopf, Contributing Writer
article
Opioid treatment leaders see the two main medication treatments for opioid use disorders as complementary options.

Pages

Subscribe to Medication